Judge Tells Attys IP Testimony Is 'Dense,' But 'It's Your Case'
A California federal judge presiding over a jury trial over claims Novartis infringed a Daiichi Sankyo subsidiary's billion-dollar skin cancer treatment patents questioned the usefulness of the day's "dense" trial testimony...To view the full article, register now.
Already a subscriber? Click here to view full article